IRVINE, Calif., July 15, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, ...
MISSISSAUGA, ON, July 29, 2021 /CNW/ -- Edwards Lifesciences (Canada) Inc. has announced it received regulatory approval from Health Canada for both the KONECT RESILIA aortic valved conduit and the ...
(RTTNews) - Edwards Lifesciences Corp. (EW) has received approval from the U.S. FDA for the KONECT RESILIA aortic valved conduit, the first ready-to-implant solution for bio-Bentall procedures. The ...
Cardiovascular surgeons who use bovine tissue valves for Bentall procedures no longer need to spend valuable operating room time manually assembling a valve with a conduit in the operating room.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback